Burden of residual risk: Are triglycerides a risk marker?

10' education - Aug. 18, 2020 - Prof. Klaus Parhofer, MD - University Hospital Munich, Germany

Video navigation menu

Residual risk - hyperlipoproteinemia 02:25
Hypertriglyceridemia and atherosclerotic events 04:20
Hypertriglyceridemia and aortic valve stenosis 08:10
Important approximates of lipid-associated CV risk 10:09
Lipid goals in combined hyperlipoproteinemia 13:16

Do you think that triglycerides play a causal role in CVD?

Educational information

This lecture by prof. Klaus Parhofer, MD is part of the virtual symposium "Reducing Residual Risk for Cardiovascular Disease: Is there a role for non-LDL lowering agents?" from the German Cardiac Society.

Faculty

Prof. Klaus Parhofer, MD – medical Clinic IV Groβhadern, University Hospital Munich, Germany

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Amarin.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.